Announcements

Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease

Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in IgG4-Related Disease

Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases

IsomAb Announces Nomination of Development Candidate for Peripheral Arterial Disease and Strategic Collaboration with Pfizer

MassBio Video

MassBio Video

Mabylon joined Pfizer Ignite to accelerate innovation in combating peanut allergy

Mediar gets a spark from Pfizer's Ignite scheme as lead fibrosis programs progress

Mediar Therapeutics Announces Clinical Candidates for Lead Fibrosis Programs, Strategic Collaborations and Key Leadership Addition

Pfizer Ignite: Kathy Fernando’s vision for accelerating biotech innovation

Pfizer’s Aamir Malik on Next-Generation Medical Breakthroughs* | The Atlantic Festival 2023

Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship

CellCentric announces $25m strategic investment from Pfizer